CVS HEALTH CORPORATION Deferred Foreign Income Tax Expense (Benefit)
CVS HEALTH CORPORATION (CVS) reported Deferred Foreign Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-10
- CVS HEALTH CORPORATION deferred foreign income tax expense (benefit) for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CVS HEALTH CORPORATION deferred foreign income tax expense (benefit) for fiscal 2024 was $3.00M, a 50.00% decline from fiscal 2023.
- CVS HEALTH CORPORATION deferred foreign income tax expense (benefit) for fiscal 2023 was $6.00M.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-10 |
| 2024-12-31 | $3.00M 10-K · filed 2026-02-10 |
| 2023-12-31 | $6.00M 10-K · filed 2026-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |